Alan N Baer Selected Research

carbonic anhydrase VI (gustin)

1/2019	Clinical Correlations of Novel Autoantibodies in Patients with Dry Eye.
4/2018	Utility of Novel Autoantibodies in the Diagnosis of Sjögren's Syndrome Among Patients With Dry Eye.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan N Baer Research Topics

Disease

9	Gout 04/2016 - 01/2012
7	Dry Eye Syndromes (Dry Eye Syndrome) 03/2022 - 07/2011
6	Hypertension (High Blood Pressure) 04/2016 - 01/2012
5	Rheumatic Diseases (Rheumatism) 01/2021 - 09/2006
4	Fatigue 07/2022 - 07/2011
4	Arthritis (Polyarthritis) 01/2017 - 05/2006
4	Neoplasms (Cancer) 01/2017 - 02/2006
3	COVID-19 11/2022 - 02/2021
3	Lymphoma (Lymphomas) 07/2022 - 01/2020
3	Sialadenitis 01/2022 - 01/2018
3	Pain (Aches) 01/2019 - 01/2012
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2016 - 12/2002
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2018
2	Small Fiber Neuropathy 01/2019 - 12/2017
2	Sjogren's Syndrome (Sjogren Syndrome) 01/2019 - 01/2017
2	Dermatomyositis (Dermatopolymyositis) 06/2016 - 06/2006
2	Polymyositis 06/2016 - 06/2006
2	Inclusion Body Myositis 06/2016 - 06/2006
2	Obesity 12/2013 - 07/2012
2	Arthralgia (Joint Pain) 01/2012 - 07/2011
2	Myotoxicity 01/2007 - 06/2006
2	Myositis (Idiopathic Inflammatory Myopathies) 06/2006 - 05/2006
2	Neurologic Manifestations (Neurological Manifestations) 05/2006 - 12/2002
1	Hematologic Neoplasms (Hematological Malignancy) 07/2022
1	Disease Progression 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Recurrent respiratory papillomatosis 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Hypersensitivity (Allergy) 01/2018
1	Necrosis 01/2017
1	Xerostomia 10/2016
1	Systemic Scleroderma (Systemic Sclerosis) 10/2016
1	Leukopenia 09/2015
1	Hyperuricemia 12/2013
1	Pleurisy (Pleuritis) 12/2013
1	Whipple Disease (Whipple's Disease) 12/2013
1	Fibrosis (Cirrhosis) 12/2013
1	Constrictive Pericarditis 12/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2013
1	Anemia 08/2012
1	Heart Failure 08/2012
1	Coronary Disease (Coronary Heart Disease) 08/2012
1	Infectious Arthritis (Septic Arthritis) 02/2012
1	Splenomegaly 01/2012
1	Chronic Urticaria 01/2012
1	Leukocytosis (Pleocytosis) 01/2012

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 03/2022 - 06/2010
9	Uric Acid (Urate)IBA 04/2016 - 01/2012
8	AutoantibodiesIBA 03/2021 - 06/2016
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 04/2016
4	DiureticsIBA 04/2016 - 01/2012
3	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2017
2	GlucocorticoidsIBA 11/2022 - 02/2021
2	Antinuclear AntibodiesIBA 01/2022 - 09/2015
2	Immunoglobulin G (IgG)IBA 01/2022 - 12/2013
2	AntigensIBA 01/2021 - 06/2011
2	RibonucleoproteinsIBA 01/2020 - 06/2010
2	Immunoglobulin M (IgM)IBA 12/2019 - 01/2012
2	Biological ProductsIBA 01/2019 - 08/2012
2	carbonic anhydrase VI (gustin)IBA 01/2019 - 04/2018
2	NivolumabIBA 01/2019 - 01/2017
2	IpilimumabIBA 01/2019 - 01/2017
2	Salivary Proteins and PeptidesIBA 01/2019 - 04/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2013 - 02/2012
2	ThiazidesIBA 05/2013 - 01/2012
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 05/2013 - 01/2012
2	Pharmaceutical PreparationsIBA 01/2007 - 06/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006 - 05/2006
1	Rheumatoid FactorIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 03/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	ORALIT (ORS)IBA 11/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	Immunoglobulin A (IgA)IBA 12/2019
1	avelumabIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2019
1	pembrolizumabIBA 01/2019
1	LigandsIBA 01/2019
1	CytokinesIBA 01/2018
1	HIV AntibodiesIBA 01/2018
1	ChemokinesIBA 01/2018
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 01/2018
1	AutoantigensIBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 10/2016
1	Triglycerides (Triacylglycerol)IBA 12/2013
1	InterferonsIBA 10/2012
1	Interferon-gamma (Interferon, gamma)IBA 10/2012
1	Hemoglobins (Hemoglobin)IBA 08/2012
1	propizepineIBA 07/2012

Therapy/Procedure

11	Therapeutics 07/2022 - 05/2006
2	Anesthesia 01/2019 - 04/2018
1	Complementary Therapies (Alternative Medicine) 07/2022
1	Immunomodulation 01/2018
1	Pericardiectomy 12/2013